There’s a lot of talk and confusion of the issues involved in the role of compounding pharmacies for topical ocular medications (eyedrops). Please see this interview in EyeWorld in which I am interviewed about regulatory issues. I address the special role which compounding pharmacies have played in the therapeutic process as physicians tailor therapies to individual patients. At the same time, I discuss the issues in the use of compounding pharmacies for larger populations crossing state lines.
- University of California Library and Elsevier Continue to Disagree
- NDA Partners Featured in Article on Growth of Pharma Disruptors
- Predatory journals – just say no!
- Sonoma Eye – Dr. Novack chair symposium on research and outcomes
- Pinterest takes a move AGAINST anti-science movement.
- U.S. FDA strengthens regulation of dietary supplements